Home/Filings/4/0000950170-25-018120
4//SEC Filing

Amello Jason 4

Accession 0000950170-25-018120

CIK 0001783328other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:47 PM ET

Size

5.3 KB

Accession

0000950170-25-018120

Insider Transaction Report

Form 4
Period: 2025-01-03
Amello Jason
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-03+270,000270,000 total
    Exercise: $3.06Exp: 2035-01-03Voting Common Stock (270,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.

Documents

1 file

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001451805

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:47 PM ET
Size
5.3 KB